Savara INC Form 4 insider transactions

Director An van Es-Johansson of Savara Inc. reports the acquisition of 40,000 restricted stock units and the disposal of 62,500 common stock shares.

Savara Inc. director Joseph S. McCracken acquired 40,000 restricted stock units (RSUs) that vest on December 12, 2025.

Savara Inc. director David Ramsay acquired 40,000 shares of common stock through restricted stock units that vest on December 12, 2025.

Savara Inc. director Joseph S. McCracken purchased 20,000 shares of common stock at a weighted average price of $2.9536 on November 19, 2024.

Savara Inc. director David Ramsay purchased 100,000 shares of common stock at an average price of $2.876 per share on November 18, 2024.

Savara Inc.'s Chief Medical Officer, Raymond Dennis Pratt, sold 49,950 shares of common stock to cover tax liabilities related to vesting restricted stock units.

Anne Erickson, Chief Business Officer of Savara Inc., reports a transaction involving common stock related to tax liability settlement.

Chief Commercial Officer Braden C. Parker reports acquiring 85,000 shares of common stock and 170,000 stock options in Savara Inc.

Anne Erickson, Chief Business Officer of Savara Inc., disposed of 381 shares to cover tax liabilities related to vesting restricted stock units.

Anne Erickson, Chief Business Officer of Savara Inc., reports the disposal of 381 shares of common stock to cover tax liabilities related to vesting restricted stock units.